Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2026
Bone mineral density, body composition, sex hormone levels, and insulin sensitivity in patients with Polyendocrine Metabolic Ovarian Syndrome.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
P Lopes Caroline, Maciel Gustavo Ar, Maffazioli Giovana Dn, Chedraui Peter, Macchione Renata, Mendonça das Neves Erika, Soares-Jr José Maria, Rodrigues Pereira Rosa Maria, Baracat Edmund C
Аннотация
OBJECTIVE: To evaluate bone mineral density (BMD), body composition, sex hormone levels, and insulin sensitivity in women with Polyendocrine Metabolic Ovarian Syndrome (PMOS) and compare these parameters with those of women without the syndrome.
METHODS: This cross-sectional study included 51 women with PMOS diagnosed according to the Rotterdam criteria and 30 women without the syndrome. Clinical characteristics, hormonal and metabolic profiles, body composition, and dual-energy X-ray absorptiometry-derived BMD were assessed. Women with PMOS were also stratified according to the presence or absence of insulin resistance.
RESULTS: Women with PMOS exhibited significantly higher BMD at the total body, lumbar spine, femoral neck, and total hip than controls (all p < 0.05). Among women with PMOS, those with insulin resistance had higher femoral neck BMD than those without insulin resistance (1.124 vs. 0.950 g/cm2, p = 0.01). This association remained significant after adjustment for body mass index.
CONCLUSION: Women with PMOS had higher BMD across all evaluated skeletal sites than women without the syndrome. Within the PMOS group, insulin resistance was not independently associated with BMD after adjustment for body mass index, indicating that excess body weight may be a more important determinant of bone density than insulin resistance itself.Bone mass in PMOS: new insights into hyperandrogenism and hyperinsulinemia.
METHODS: This cross-sectional study included 51 women with PMOS diagnosed according to the Rotterdam criteria and 30 women without the syndrome. Clinical characteristics, hormonal and metabolic profiles, body composition, and dual-energy X-ray absorptiometry-derived BMD were assessed. Women with PMOS were also stratified according to the presence or absence of insulin resistance.
RESULTS: Women with PMOS exhibited significantly higher BMD at the total body, lumbar spine, femoral neck, and total hip than controls (all p < 0.05). Among women with PMOS, those with insulin resistance had higher femoral neck BMD than those without insulin resistance (1.124 vs. 0.950 g/cm2, p = 0.01). This association remained significant after adjustment for body mass index.
CONCLUSION: Women with PMOS had higher BMD across all evaluated skeletal sites than women without the syndrome. Within the PMOS group, insulin resistance was not independently associated with BMD after adjustment for body mass index, indicating that excess body weight may be a more important determinant of bone density than insulin resistance itself.Bone mass in PMOS: new insights into hyperandrogenism and hyperinsulinemia.